scholarly journals Aromatase Is Increased in Astrocytes in the Presence of Elevated Pressure

Endocrinology ◽  
2011 ◽  
Vol 152 (1) ◽  
pp. 207-213 ◽  
Author(s):  
J. W. Gatson ◽  
J. W. Simpkins ◽  
K. D. Yi ◽  
A. H. Idris ◽  
J. P. Minei ◽  
...  

Abstract After traumatic brain injury (TBI), a progressive injury and death of neurons and glia leads to decreased brain function. Endogenous and exogenous estrogens may protect these vulnerable cells. In this study, we hypothesized that increased pressure leads to an increase in aromatase expression and estrogen production in astrocytes. In this study, we subjected rat glioma (C6) cells and primary cortical astrocytes to increased pressure (25 mm Hg) for 1, 3, 6, 12, 24, 48, and 72 h. Total aromatase protein and RNA levels were measured using Western analysis and RT-PCR, respectively. In addition, we measured aromatase activity by assaying estrone levels after administration of its precursor, androstenedione. We found that increased pressure applied to the C6 cells and primary cortical astrocytes resulted in a significant increase in both aromatase RNA and protein. To extend these findings, we also analyzed aromatase activity in the primary astrocytes during increased pressure. We found that increased pressure resulted in a significant (P < 0.01) increase in the conversion of androstenedione to estrone. In conclusion, we propose that after TBI, astrocytes sense increased pressure, leading to an increase in aromatase production and activity in the brain. These results may suggest mechanisms of brain estrogen production after increases in pressure as seen in TBI patients.

1988 ◽  
Vol 94 (3) ◽  
pp. 279-284 ◽  
Author(s):  
P.W.L. Tas ◽  
H.G. Kress ◽  
K. Koschel
Keyword(s):  
C6 Cells ◽  

2020 ◽  
Vol 122 (7) ◽  
pp. 151625
Author(s):  
Marta Hałas-Wiśniewska ◽  
Magdalena Izdebska ◽  
Wioletta Zielińska ◽  
Alina Grzanka

2009 ◽  
Vol 2009 (8) ◽  
pp. 511-514 ◽  
Author(s):  
Xiang-Yang Qin ◽  
Gui-Rong Ding ◽  
Xiao-Wu Wang ◽  
Juan Tan ◽  
Guo-Zhen Guo ◽  
...  

Nitroxyl compounds have been previously investigated as potential radioprotection drugs. To develop new radioprotectors, two kinds of novel chiral nitronyl nitroxyl radicals: L- tert-butyl 2-(4, 5-dihydro-4, 4, 5, 5-tetramethyl-3-oxido-1 H-imidazol-3-ium-1-oxyl-2-yl) pyrrolidine-1-carboxylate ( L-NNP) and L- tert-butyl 2-[(4-(4, 5-dihydro-4,4,5,5-tetramethyl-3-oxido-1 H-imidazol-3-ium-1-oxyl-2-yl)-2-methoxyphenoxy)methyl] pyrrolidine-1-carboxylate ( L-NNVP) have been synthesised. The cytotoxic and radioprotective effects of these two compounds were then evaluated in rat glioma C6 cells.


Blood ◽  
2006 ◽  
Vol 109 (5) ◽  
pp. 2205-2209 ◽  
Author(s):  
Ivana De Domenico ◽  
Diane McVey Ward ◽  
Giovanni Musci ◽  
Jerry Kaplan

Abstract Ferroportin (Fpn) (IREG1, SLC40A1, MTP1) is an iron transporter, and mutations in Fpn result in a genetically dominant form of iron overload disease. Previously, we demonstrated that Fpn is a multimer and that mutations in Fpn are dominant negative. Other studies have suggested that Fpn is not a multimer and that overexpression or epitope tags might affect the localization, topology, or multimerization of Fpn. We generated wild-type Fpn with 3 different epitopes, GFP, FLAG, and c-myc, and expressed these constructs in cultured cells. Co-expression of any 2 different epitope-tagged proteins in the same cell resulted in their quantitative coimmunoprecipitation. Treatment of Fpn-GFP/Fpn-FLAG–expressing cells with crosslinking reagents resulted in the crosslinking of Fpn-GFP and Fpn-FLAG. Western analysis of rat glioma C6 cells or mouse bone marrow macrophages exposed to crosslinking reagents showed that endogenous Fpn is a dimer. These results support the hypothesis that the dominant inheritance of Fpn–iron overload disease is due to the dominant-negative effects of mutant Fpn proteins.


Neuropeptides ◽  
1995 ◽  
Vol 29 (5) ◽  
pp. 251-256 ◽  
Author(s):  
R Kaufmann ◽  
T Schöneberg ◽  
C Lindschau ◽  
H Haller ◽  
T Ott
Keyword(s):  
C6 Cells ◽  

1995 ◽  
Vol 81 (2-3) ◽  
pp. 189-195 ◽  
Author(s):  
Klaus Koschel ◽  
Nicole N. Meissner ◽  
Piet W.L. Tas

Neuropeptides ◽  
1998 ◽  
Vol 32 (2) ◽  
pp. 185-189 ◽  
Author(s):  
R Kaufmann ◽  
H Schafberg ◽  
M Zieger ◽  
P Henklein ◽  
G Nowak

Sign in / Sign up

Export Citation Format

Share Document